Cambridge-based Foghorn Therapeutics plans to expand into a new 60,000-square-foot headquarters at 500 Technology Square in Kendall Square, nearly tripling its former headquarters.
The company employs more than 80, and the new office and lab has room for growth.
“There is no specific timeframe for filling the new office to capacity but Foghorn has grown rapidly since its inception and we are regularly adding talented individuals to help us achieve our mission,” a spokesperson said in an email.
In 2016, Dr. Gerald Crabtree, Dr. Doug Cole and Cigall Kadoch founded Foghorn, which says it’s planning to develop drugs the work on the so-called the chromatin regulatory system, which it says “orchestrates the movement of molecules that turn genes ‘on’ and ‘off.’”
